Hepatitis C virus–cell interactions and their role in pathogenesis (Q35105690)

6 August 2017

1 reference

title

Hepatitis C virus--cell interactions and their role in pathogenesis (English)

1 reference

6 August 2017

Hepatitis C virus–cell interactions and their role in pathogenesis (English)

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(02)00075-2

23 December 2023

1 reference

Stephen J. Polyak

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691459

23 December 2023

language of work or name

1 reference

1 February 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S1089326102000752?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(02)00075-2

https://api.elsevier.com/content/article/PII:S1089326102000752?httpAccept=text/plain

23 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(02)00075-2

23 December 2023

published in

Clinics in liver disease

1 reference

6 August 2017

7

1 reference

6 August 2017

1

1 reference

6 August 2017

67-88

1 reference

Hepatitis C viral infection in liver transplant recipients

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Epidemiology of hepatitis C virus infection in Italy: the slowly unraveling mystery

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Epidemiology of hepatitis C: geographic differences and temporal trends

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Analysis of a successful immune response against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Therapy of hepatitis C: overview

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Association of hepatitis C virus in human sera with beta-lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Binding of hepatitis C virus to CD81

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Chemokines and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Three classes of cell surface receptors for alphaherpesvirus entry

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Detection of hepatitis C virus RNA in peripheral blood mononuclear cells and in saliva

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

The presence of active hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Examination of potential inhibitors of hepatitis A virus uncoating

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Mechanism of lymphocytic choriomeningitis virus entry into cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Inhibition of Semliki forest virus penetration by lysosomotropic weak bases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Low pH-induced cell fusion in flavivirus-infected Aedes albopictus cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

The hepatitis C virus: overview

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3'-untranslated sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C Virus 3'X Region Interacts with Human Ribosomal Proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Biosynthesis and biochemical properties of the hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Description of a procedure which allows isolation of viral nonstructural proteins from BHK vertebrate cells infected with the West Nile flavivirus in a state which allows their direct chemical characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

The sensitivity of cell-associated dengue virus proteins to trypsin and the detection of trypsin-resistant fragments of the nonstructural glycoprotein NS1.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Phosphorylation of nonstructural 5A protein of hepatitis C virus: HCV group-specific hyperphosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Identification of the major phosphorylation site of the hepatitis C virus H strain NS5A protein as serine 2321

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Ser(2194) is a highly conserved major phosphorylation site of the hepatitis C virus nonstructural protein NS5A.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus NS5A protein is phosphorylated in vitro by a stably bound protein kinase from HeLa cells and by cAMP-dependent protein kinase A-alpha catalytic subunit

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus NS5A protein is phosphorylated by casein kinase II.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Efficient initiation of HCV RNA replication in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Mutational analysis of the structure and functions of hepatitis C virus RNA-dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Emergence of a distinct pattern of viral mutations in chimpanzees infected with a homogeneous inoculum of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Regulation of mRNA Translation and Cellular Signaling by Hepatitis C Virus Nonstructural Protein NS5A

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Analyzing the mechanisms of interferon-induced apoptosis using CrmA and hepatitis C virus NS5A.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor alpha-stimulated nuclear factor kappa B activation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease(s) in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Suppression of apoptotic cell death by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus core protein enhances the activation of the transcription factor, Elk1, in response to mitogenic stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus core protein: possible roles in viral pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

The hepatitis C virus core protein interacts with NS5A and activates its caspase-mediated proteolytic cleavage

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Translational control perks up

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Suppression of interferon-induced antiviral activity in cells expressing hepatitis C virus proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Interleukin-8 selectively enhances cytopathic effect (CPE) induced by positive-strand RNA viruses in the human WISH cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Predictors of sustained response to alpha interferon therapy in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Activation of the interferon-inducible 2'-5'-oligoadenylate synthetase gene by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900075-2

7 January 2021

The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients

20

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(02)00075-2

Detection of hepatitis C virus RNA in serum and peripheral blood mononuclear cells

23 December 2023

40

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(02)00075-2

Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A

23 December 2023

73

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(02)00075-2

The NS5A/NS5 proteins of viruses from three genera of the family flaviviridae are phosphorylated by associated serine/threonine kinases

23 December 2023

77

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(02)00075-2

Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation

23 December 2023

143

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(02)00075-2

23 December 2023

Identifiers

1 reference

6 August 2017

1 reference